BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1832988)

  • 1. Effects of D1 and D2 antagonists on apomorphine-induced responses of ventral pallidal neurons.
    Maslowski RJ; Napier TC
    Neuroreport; 1991 Aug; 2(8):451-4. PubMed ID: 1832988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D1 and D2 receptor agonists induce opposite changes in the firing rate of ventral pallidal neurons.
    Maslowski RJ; Napier TC
    Eur J Pharmacol; 1991 Jul; 200(1):103-12. PubMed ID: 1685119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the amygdala and nucleus accumbens to ventral pallidal responses to dopamine agonists.
    Napier TC
    Synapse; 1992 Feb; 10(2):110-9. PubMed ID: 1350111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function.
    Heidenreich BA; Mitrovic I; Battaglia G; Napier TC
    Exp Neurol; 2004 Apr; 186(2):145-57. PubMed ID: 15026253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine electrophysiology of ventral pallidal/substantia innominata neurons: comparison with the dorsal globus pallidus.
    Napier TC; Simson PE; Givens BS
    J Pharmacol Exp Ther; 1991 Jul; 258(1):249-62. PubMed ID: 1677041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multisecond oscillations in firing rate in the globus pallidus: synergistic modulation by D1 and D2 dopamine receptors.
    Ruskin DN; Bergstrom DA; Walters JR
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1493-501. PubMed ID: 10454529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study.
    Carlson JH; Bergstrom DA; Walters JR
    Brain Res; 1987 Jan; 400(2):205-18. PubMed ID: 2880637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
    Napier TC; Maslowski-Cobuzzi RJ
    Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of dopaminergic neurons modulates ventral pallidal responses evoked by amygdala stimulation.
    Maslowski-Cobuzzi RJ; Napier TC
    Neuroscience; 1994 Oct; 62(4):1103-19. PubMed ID: 7845589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons.
    Napier TC; Givens BS; Schulz DW; Bunney BS; Breese GR; Mailman RB
    J Pharmacol Exp Ther; 1986 Mar; 236(3):838-45. PubMed ID: 3512819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists.
    Carlson JH; Bergstrom DA; Walters JR
    Eur J Pharmacol; 1986 Apr; 123(2):237-51. PubMed ID: 2940101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topography of dopamine D-1 and D-2 receptor-mediated rotation after intrastriatal injections of dopamine-related drugs in normosensitive rats.
    Konitsiotis S; Kafetzopoulos E
    Eur J Pharmacol; 1990 Apr; 179(1-2):201-5. PubMed ID: 2142084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptor regulation of ethanol intake and extracellular dopamine levels in the ventral pallidum of alcohol preferring (P) rats.
    Melendez RI; Rodd ZA; McBride WJ; Murphy JM
    Drug Alcohol Depend; 2005 Mar; 77(3):293-301. PubMed ID: 15734229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D2 antagonist-induced c-fos in an identified subpopulation of globus pallidus neurons by a direct intrapallidal action.
    Billings LM; Marshall JF
    Brain Res; 2003 Feb; 964(2):237-43. PubMed ID: 12576184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial and full dopamine D1 agonists produce comparable increases in ventral pallidal neuronal activity: contribution of endogenous dopamine.
    Heidenreich BA; Mailman RB; Nichols DE; Napier TC
    J Pharmacol Exp Ther; 1995 Apr; 273(1):516-25. PubMed ID: 7714807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the globus pallidus D2 subfamily of dopamine receptors in pallidal immediate early gene expression.
    Marshall JF; Henry BL; Billings LM; Hoover BR
    Neuroscience; 2001; 105(2):365-78. PubMed ID: 11672604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphine.
    Mereu G; Collu M; Ongini E; Biggio G; Gessa GL
    Eur J Pharmacol; 1985 May; 111(3):393-6. PubMed ID: 3894035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus.
    Carlson JH; Bergstrom DA; Demo SD; Walters JR
    Synapse; 1990; 5(2):83-93. PubMed ID: 2309160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.